Filtern
Dokumenttyp
- Posterpräsentation (9)
- Zeitschriftenartikel (4)
- Dissertation (1)
- Vortrag (1)
Sprache
- Englisch (15) (entfernen)
Schlagworte
- Amoxicillin (11)
- Diclofenac (8)
- Immunoassay (8)
- Immunosensor (6)
- Magnetic Beads (6)
- Water Analysis (4)
- LC-MS/MS (3)
- Microfluidics (3)
- Antibiotics (2)
- Electrochemistry (2)
- Hydrolysis (2)
- Hydrolysis products (2)
- ICP-MS (2)
- Amperometry (1)
- Antibodies (1)
- Biosensor (1)
- Chronoamperometry (1)
- Degradation (1)
- ELISA (1)
- Electrochemical (1)
- Elektrochemie (1)
- Immunassay (1)
- Magnetic Particles (1)
- Magnetic beads (1)
- Microfluidic (1)
- Mikrofluidik (1)
- Online Sensing (1)
- Stability (1)
- Water analysis (1)
- β-Lactam (1)
- β-lactam (1)
Organisationseinheit der BAM
Paper des Monats
- ja (1)
Eingeladener Vortrag
- nein (1)
We report the first results for the immunochemical determination of the β-lactam antibiotic drug amoxicillin (AMX) in water samples by ELISA (enzyme-linked immunosorbent assay). The applied indirect competitive ELISA using a commercially available mouse anti-AMX antibody enables testing for AMX with a limit of detection of around 1 µg/L. Calibration curves of calibrators prepared in different water samples showed equal shape. This underlines the suitability of this assay for the AMX determination in these samples. Furthermore, cross-reactivities of structurally similar β-lactam antibiotics were examined and found to be low for ampicillin, penicillin G and penicillin V. In contrast, carbenicillin was recognized by the antibody even better than AMX indicating a positive effect of an additional carboxyl group on antibody binding. This is promising for further application of this assay, e.g. in the determination of the most relevant hydrolysis product of AMX, amoxicilloic acid.
Herein we present the data for a newly developed immunoassay for the determination of amoxicillin (AMX) in water samples using a commercially available monoclonal anti-AMX antibody. During optimization and testing of the assay, we observed a significant decrease of the C-value (IC50) of the ELISA calibration curves with aged standard solutions. Running the assay with standard solutions of synthesized AMX hydrolysis products revealed that this decreased C-value could be attributed mainly to the hydrolysis product amoxicilloic acid. Therefore, the limit of detection of the ELISA for AMX determination in water could be enhanced by either hydrolyzing the samples or testing for amoxicilloic acid as marker substance.
Increasing contamination of environmental waters with pharmaceuticals represents an emerging threat for the drinking water quality and safety. In this regard, fast and reliable analytical methods are required to allow quick countermeasures in case of contamination. Here, we report the development of a magnetic bead-based immunoassay (MBBA) for the fast and cost-effective determination of the analgesic diclofenac (DCF) in water samples, based on diclofenac-coupled magnetic beads and a robust monoclonal anti-DCF antibody. A novel synthetic strategy for preparation of the beads resulted in an assay that enabled for the determination of diclofenac with a significantly lower limit of detection (400 ng/L) than the respective enzyme-linked immunosorbent assay (ELISA). With shorter incubation times and only one manual washing step required, the assay demands for remarkably shorter time to result (< 45 min) and less equipment than ELISA. Evaluation of assay precision and accuracy with a series of spiked water samples yielded results with low to moderate intra- and inter-assay variations and in good agreement with LC–MS/MS reference analysis. The assay principle can be transferred to other, e.g., microfluidic, formats, as well as applied to other analytes and may replace ELISA as the standard immunochemical method.
Contamination of drinking water with pharmaceuticals is an emerging problem and a potential health threat. Immunochemical methods based on the binding of the analyte to specific antibodies enable fast and cost-effective on-site analyses. Magnetic bead-based immunoassays allow for implementation into an immunosensor for online testing. These particles are prepared by either coupling the analyte molecule (diclofenac) or the respective antibody (amoxicillin) to the surface. For miniaturization, detection is performed electrochemically on a microfluidic chip. The developed immunosensor will enable detection of pharmaceuticals directly in water supply pipes.
Contamination of drinking water with pharmaceuticals is an emerging problem and a potential health threat. Immunochemical methods based on the binding of the analyte to specific antibodies enable fast & cost-effective on-site analyses. Magnetic bead-based immunoassays allow for implementation into an immunosensor for online testing. Particles are prepared by either coupling the analyte molecule (diclofenac) or the respective antibody (amoxicillin) to the surface. For miniaturization, detection is performed electrochemically (chronoamperometry) on a microfluidic chip. The developed immunosensor will enable detection of pharmaceuticals directly in water supply pipes.
We present the development of magnetic bead-based immunoassays for two potential contaminants of drinking water: the nonsteroidal anti-inflammatory drug diclofenac and the broad-spectrum antibiotic amoxicillin. For these analytes, different assay formats were developed which can generally be transferred to other analytes. The use of magnetic beads not only enables implementation of the assays into an online system since the beads can be reversibly immobilized by applying a magnetic field. Furthermore, our MBBAs hold several advantages over the conventional ELISAs (enzyme-linked immunosorbent assays) for both analytes, such as lower limits of quantification, shorter assay duration and less washing steps required.
Strategies for the setup and miniaturization of an online immunosensor including electrochemical readout on a microfluidic chip will be discussed.
Contamination of waters with pharmaceuticals is an alarming problem as it may support the evolution of antimicrobial resistance. Therefore, fast and cost-effective analytical methods for potential on-site analysis are desired in order to control the water quality and assure the safety of its use as a source of drinking water. Antibody-based methods, such as the enzyme-linked immunosorbent assay (ELISA), can be helpful in this regard but can also have certain pitfalls in store, depending on the analyte. As shown here for the class of β-lactam antibiotics, hydrolysis of the β-lactam ring is a key factor in the immunochemical analysis as it influences antibody recognition. With the antibody used in this study, the limit of detection (LOD) in the immunoassay could be significantly reduced by hydrolysis for the five tested penicillins, with the lowest LOD for carbenicillin (0.2 nmol/L) and the greatest impact on penicillins G and V (reduction by 85%). In addition to enhanced quantification, our strategy also provides access to information about the degree of hydrolysis in water samples as shown for the most abundant penicillin amoxicillin.
The demand for quick and reliable online sensors is rising not only in the field of environmental analysis with new and diversifying sources of pollution. A major aspect of this is the contamination of (drinking) water with pharmaceuticals representing a potential health threat and requiring timely countermeasures in case of contamination.
In this regard, antibody-based methods can be helpful as they enable fast and cost-effective on-site and potentially online analyses. The transition from the conventional plate-based formats like ELISA (enzyme-linked immunosorbent assay) to an immunosensor fit for online sensing can be achieved by using magnetic microparticles as a mobile sensing platform.
Beads are prepared by either coupling the antibody or the analyte to the surface. Both these strategies are presented using the example of two relevant contaminants in water: diclofenac (DCF) & amoxicillin (AMX), and can be transferred to other analytes.
The developed magnetic bead-based assays (MBBAs) exhibit lower LODs, enhanced sensitivity as well as shorter time of analysis than the respective ELISAs and can be integrated into an immunosensor with electrochemical detection on a microfluidic chip.
Contamination of drinking water with pharmaceuticals is an emerging problem and a potential health threat. Immunochemical methods based on the binding of the analyte to specific antibodies enable fast & cost-effective on-site analyses. Magnetic bead-based immunoassays (MBBAs) allow for implementation into an immunosensor for online testing. Particles are prepared by either coupling the analyte molecule (diclofenac) or the respective antibody (amoxicillin) to the surface. For miniaturization, detection is performed electrochemically (chronoamperometry) on a microfluidic chip. The developed immunosensor will enable detection of pharmaceuticals directly in water supply pipes.
Contamination of drinking water with pharmaceuticals is an emerging problem and a potential health threat. Immunochemical methods based on the binding of the analyte to specific antibodies enable fast & cost-effective on-site analyses. Magnetic bead-based immunoassays (MBBAs) allow for implementation into an immunosensor for online testing. Particles are prepared by either coupling the analyte molecule (diclofenac) or the respective antibody (amoxicillin) to the surface. For miniaturization, detection is performed electrochemically (chronoamperometry) on a microfluidic chip. The developed immunosensor will enable detection of pharmaceuticals directly in water supply pipes.